Parturient-controlled epidural analgesia during labour: bupivacaine vs. ropivacaine
| Autor: | N. P. Chua, Alex Tiong Heng Sia, C. E. Ocampo |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Adult
medicine.medical_specialty medicine.drug_class Pain relief Drug Administration Schedule Bolus (medicine) Double-Blind Method Pregnancy medicine Humans Ropivacaine Prospective Studies Anesthetics Local Pain Measurement Bupivacaine Local anesthetic business.industry Pregnancy Outcome Analgesia Patient-Controlled Amides Surgery Analgesia Epidural Regimen Anesthesiology and Pain Medicine Patient Satisfaction Anesthesia Analgesia Obstetrical Fetal outcome Female Self-administration business medicine.drug |
| Zdroj: | Anaesthesia. 56:1169-1173 |
| ISSN: | 1365-2044 0003-2409 |
| DOI: | 10.1046/j.1365-2044.2001.02321.x |
| Popis: | In this randomised, controlled study, we compared the hourly dose requirement of ropivacaine 0.125% (group R, n = 16) with bupivacaine 0.125% (group B, n = 16) provided by demand-only (bolus 5 ml, lockout 10 min) parturient-controlled epidural analgesia during labour. The hourly dose requirement was comparable although group R had a lower successful to total demands ratio (p < 0.05). We also found that both groups were clinically indistinguishable in terms of pain relief and side-effects. No difference in maternal or fetal outcome was detected. We conclude that, at a concentration of 0.125%, ropivacaine and bupivacaine were equally effective when self-administered using this patient-controlled regimen. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text